NASDAQ:ARDS

Aridis Pharmaceuticals - ARDS News Today

$0.71

-0.09 (-11.25%)

(As of 01/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.64
▼
$0.78
50-Day Range: $0.71
▼
$1.50
52-Week Range: $0.57
▼
$2.94

Volume: 3.12 million shs
Average Volume: 2.13 million shs
Market Capitalization: $14.77 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $6.00

Institutional Ownership

Get Aridis Pharmaceuticals News Delivered to You Automatically

ARDS Media Mentions By Week

ARDS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARDS
News Sentiment
▼
0.10

0.72
▲
Average
Medical
News Sentiment

ARDS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARDS Articles
This Week
▼
8

0
▲
ARDS Articles
Average Week

Source

Source	Headline
	Analysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP), Aridis Pharmaceuticals (ARDS) and Acurx Pharmaceuticals (ACXP) markets.businessinsider.com - January 27 at 8:30 AM
	HC Wainwright Cuts Aridis Pharmaceuticals (NASDAQ:ARDS) Price Target to $10.00 americanbankingnews.com - January 27 at 8:12 AM
	Aridis stock slumps ~25% as antibody drug fails phase 3 trial in pneumonia msn.com - January 26 at 9:52 AM
	Aridis Reports Top-Line Results of the Phase 3 Double-Blinded, Superiority Trial of AR-301 For the Treatment of Staphylococcus aureus Ventilator Associated Pneumonia (VAP) finance.yahoo.com - January 25 at 6:34 PM
	New Approaches to Treating Infections in Cystic Fibrosis Patients - AR 501 Phase 2 Trial Update finance.yahoo.com - January 17 at 7:06 PM
	Aridis Pharmaceuticals to Discuss Topline Data from Phase 3 Study of AR-301 During Corporate Update Call on January 25 finance.yahoo.com - December 28 at 1:24 PM
	(Updated) Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation finance.yahoo.com - December 12 at 5:26 PM
	Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation finance.yahoo.com - December 12 at 7:32 AM
	Aridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan-Ebola and Pan-Marburg Monoclonal Antibody Programs from Mapp Biopharmaceutical finance.yahoo.com - December 5 at 3:43 PM
	Aridis Announces a Key Milestone of Closing of Patient Enrollment in the Phase 2a Study of AR-501 in Cystic Fibrosis Patients finance.yahoo.com - November 30 at 8:32 AM
	Aridis to Participate in Key Opinion Leader Discussion on Immunotherapy for Infectious Diseases finance.yahoo.com - November 22 at 4:37 PM
	Aridis Pharmaceuticals, Inc.: Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update finanznachrichten.de - November 22 at 3:06 AM
	Aridis Pharmaceuticals Late Monday Reported Q3 EPS $(0.47) Up From $(1.94) YoY, Sales $399.00K Down From $515.00K YoY benzinga.com - November 22 at 3:06 AM
	Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update finance.yahoo.com - November 21 at 10:05 PM
	Aridis Pharmaceuticals (ARDS) Reports Q3 Loss, Misses Revenue Estimates finance.yahoo.com - November 21 at 10:05 PM
	DICE Therapeutics (DICE) Up on Top-Line Data From Psoriasis Study finance.yahoo.com - October 12 at 2:32 PM
	scPharmaceuticals (SCPH) Plunges Despite Furoscix's FDA Approval finance.yahoo.com - October 11 at 11:02 PM
	Aridis Announces the Closing of Patient Enrollment in the AR-301 Global Phase 3 Superiority Study finance.yahoo.com - October 4 at 9:29 AM
	Aridis Pharmaceuticals Announces Proposed Public Offering of Common Stock finance.yahoo.com - September 26 at 7:21 PM
	Wave Therapeutics (WVE) Up on Update From Huntington's Study finance.yahoo.com - September 21 at 3:29 PM
	ARDS Aridis Pharmaceuticals, Inc. seekingalpha.com - September 20 at 11:03 PM
	bluebird's (BLUE) Gene Therapy Gets FDA Nod for CALD finance.yahoo.com - September 19 at 2:18 PM
	Intellia (NTLA) Reports Positive Results for CRISPR Candidates finance.yahoo.com - September 19 at 2:18 PM
	Aridis Pharmaceuticals, Inc. (ARDS) uk.finance.yahoo.com - September 16 at 12:38 AM
	Aridis Pharmaceuticals GAAP EPS of -$0.45, revenue of $0.29M seekingalpha.com - August 17 at 7:41 PM
	Aridis Pharmaceuticals (ARDS) Reports Q2 Loss, Misses Revenue Estimates finance.yahoo.com - August 16 at 11:39 PM
	Aridis Pharmaceuticals Announces Second Quarter 2022 Financial Results and Business Update finance.yahoo.com - August 16 at 6:38 PM
	Aridis' Inhaled Pan-Coronavirus Antibody Cocktail Shows Encouraging Preclinical Action finance.yahoo.com - August 10 at 5:19 PM
	Aridis' Pan-Coronavirus, Inhaled Monoclonal Antibody Cocktail AR-701 Is Protective in Non-Human Primates finance.yahoo.com - August 10 at 12:18 PM
	Here's Why Aridis Pharmaceuticals (ARDS) Looks Ripe for Bottom Fishing nasdaq.com - July 1 at 4:49 PM
	RedChip Interviews Aridis Pharmaceuticals’ CEO Vu Truong apnews.com - July 1 at 11:48 AM
	RedChip Interviews Aridis Pharmaceuticals' CEO Vu Truong finance.yahoo.com - June 30 at 10:31 AM
	Aridis Pharmaceuticals CEO to Participate in a Fireside Chat Presented by Maxim Group LLC and Hosted by M-Vest on June 7 finance.yahoo.com - June 3 at 10:03 AM
	Aridis Pharmaceuticals (ARDS) Reports Q1 Loss, Lags Revenue Estimates finance.yahoo.com - May 16 at 10:15 PM
	Aridis Pharmaceuticals Announces First Quarter 2022 Financial Results and Business Update finance.yahoo.com - May 16 at 5:14 PM
	Aridis Pharma COVID-19 Antibody Neutralizes Omicron Variant In Animal Study finance.yahoo.com - February 17 at 3:37 PM
	Aridis stock rises 6% as antibody cocktail AR-701 protects against Omicron in animal models seekingalpha.com - February 17 at 10:36 AM
	Why Aridis Pharma Is Rising In Pre-market? nasdaq.com - February 17 at 10:36 AM
	Aridis' Pan-Coronavirus Monoclonal Antibody Cocktail AR-701 Is Protective in COVID-19 Omicron Infected Animals finance.yahoo.com - February 17 at 10:36 AM
	Wolfspeed, Galapagos, BlackBerry among premarket losers' pack seekingalpha.com - January 31 at 9:19 AM
	How Is The Market Feeling About Aridis Pharmaceuticals Inc? benzinga.com - January 28 at 1:57 PM
	Peering Into Aridis Pharmaceuticals Inc's Recent Short Interest msn.com - January 27 at 5:56 PM
	Aridis Shares Rise On Funding For Inhaled Monoclonal Antibodies Against Influenza, COVID-19 finance.yahoo.com - January 27 at 12:51 PM
	Looking Into Aridis Pharmaceuticals Inc's Recent Short Interest msn.com - January 27 at 12:51 PM
	(ARDS) - Analyzing Aridis Pharmaceuticals Inc's Short Interest msn.com - January 27 at 12:51 PM
	Aridis Gets $1.9 Mln Funding From Gates Foundation To Fight Influenza, Covid-19 In Poor Countries markets.businessinsider.com - January 27 at 7:51 AM
	Aridis wins funding from Gates Foundation to test inhalational COVID-19 antibodies seekingalpha.com - January 27 at 7:51 AM
	Aridis Pharmaceuticals Receives Funding to Evaluate Inhaled Monoclonal Antibodies to Block Influenza and SARS-CoV-2 Transmission finance.yahoo.com - January 27 at 7:51 AM
	Pre-market Movers: KPRX, CTK, VGR, BVXV, NEW… markets.businessinsider.com - December 30 at 7:44 AM
	H.C. Wainwright Bullish on Aridis Pharmaceuticals Covid-19 Antibody Cocktail finance.yahoo.com - December 29 at 3:12 PM

Get Aridis Pharmaceuticals News Delivered to You Automatically

This page (NASDAQ:ARDS) was last updated on 1/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Aridis Pharmaceuticals - ARDS News Today

ARDS Media Mentions By Week

ARDS Media Sentiment

ARDS News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info